Your browser doesn't support javascript.
loading
Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer.
Mortensen, H R; Populaire, P; Hoffmann, L; Moeller, D S; Appelt, A; Nafteux, P; Muijs, C T; Grau, C; Hawkins, M A; Troost, E G C; Defraene, G; Canters, R; Clarke, C S; Weber, D C; Korevaar, E W; Haustermans, K; Nordsmark, M; Gebski, Val; Achiam, M P; Markar, Sheraz R; Radhakrishna, Ganesh; Berbee, Maaike; Scartoni, Daniele; Orlandi, Ester; Doyen, Jerome; Gregoire, Vincent; Crehange, Gilles; Langendijk, Johannes; Lorgelly, Paula; Blommenstein, Hedwig M; Byskov, Camilla S; Ehmsen, Mai L; Jensen, Maria Fuglsang; Freixas, Gloria Vilches; Bütof, Rebecca.
Afiliação
  • Mortensen HR; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.
  • Populaire P; University Hospitals Leuven, Department of Radiation Oncology, Belgium; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium.
  • Hoffmann L; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.
  • Moeller DS; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Aarhus, Denmark.
  • Appelt A; University of Leeds, Leeds, UK.
  • Nafteux P; University Hospitals Leuven, Department of Thoracic Surgery, Belgium.
  • Muijs CT; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Grau C; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Hawkins MA; Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
  • Troost EGC; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universit
  • Defraene G; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium.
  • Canters R; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, the Netherlands.
  • Clarke CS; Research Dept. of Primary Care and Population Health, University College London, London, UK.
  • Weber DC; Center for Proton Therapy, Paul Scherrer Institut, Villigen, Switzerland; Radiation Oncology Department, University Hospital Zurich, Zurich, Switzerland.
  • Korevaar EW; Department of Radiation Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Haustermans K; University Hospitals Leuven, Department of Radiation Oncology, Belgium; KU Leuven- University of Leuven, Department of Oncology, Laboratory of Experimental Radiotherapy, Leuven, Belgium.
  • Nordsmark M; Department of Oncology and Medical Physics, Aarhus University Hospital, Aarhus, Denmark.
  • Gebski V; NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW, Australia.
  • Achiam MP; Dept. Surgery and Transplantation, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Markar SR; Department of General Surgery, Oxford University Hospitals, Oxford, UK; Nuffield Department of Surgery, University of Oxford, Oxford, UK.
  • Radhakrishna G; The Christie, Manchester, United Kingdom.
  • Berbee M; Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Scartoni D; Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
  • Orlandi E; National Center for Oncological Hadrontherapy (CNAO), Radiation Oncology Clinical Department, Pavia, Italy.
  • Doyen J; Centre Antoine Lacassagne, Nice, France.
  • Gregoire V; Centre Léon Bérard, 28 rue Laennec, Lyon 69373 Cedex 08, France.
  • Crehange G; PSL Research University, RadiationOncology Department, Institut Curie, Paris/Orsay, France.
  • Langendijk J; Department of Radiation Oncology, UniversityMedicalCentreGroningen, Groningen, The Netherlands.
  • Lorgelly P; University of Auckland, Waipara Taumata Rau, Auckland, New Zealand.
  • Blommenstein HM; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, Rotterdam, 3000 DR, The Netherlands; Erasmus Centre for Health Economics Rotterdam, Erasmus University, Rotterdam, The Netherlands.
  • Byskov CS; Department of Oncology and Medical physics, Aarhus University Hospital, Aarhus, Denmark.
  • Ehmsen ML; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Jensen MF; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.
  • Freixas GV; Maastro Proton Therapy, Department of Radiation Oncology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Bütof R; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden and OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dre
Radiother Oncol ; 190: 109980, 2024 01.
Article em En | MEDLINE | ID: mdl-37935284
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Terapia Neoadjuvante Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Terapia Neoadjuvante Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article